Cambridge Investment Research Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 3,510 shares of BMRN stock, worth $216,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,510

Previous 3,070 14.33%

Holding current value

$216,672

Previous $253,000 2.37%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$69.02 - $93.84 $30,368 - $41,289	440 Added 14.33%	3,510 $247,000
Q2 2024 Jul 26, 2024	BUY	$74.43 - $92.22 $39,001 - $48,323	524 Added 20.58%	3,070 $253,000
Q1 2024 Apr 24, 2024	SELL	$83.81 - $99.0 $25,562 - $30,195	-305 Reduced 10.7%	2,546 $222,000
Q4 2023 Feb 09, 2024	BUY	$76.22 - $98.51 $3,201 - $4,137	42 Added 1.5%	2,851 $275,000
Q3 2023 Oct 24, 2023	SELL	$85.07 - $94.48 $106,592 - $118,383	-1,253 Reduced 30.85%	2,809 $249,000
Q2 2023 Jul 13, 2023	SELL	$86.68 - $100.3 $89,020 - $103,008	-1,027 Reduced 20.18%	4,062 $352,000
Q1 2023 May 11, 2023	SELL	$87.74 - $117.27 $92,039 - $123,016	-1,049 Reduced 17.09%	5,089 $495,000
Q4 2022 Feb 08, 2023	BUY	$80.93 - $108.63 $37,227 - $49,969	460 Added 8.1%	6,138 $635,000
Q3 2022 Oct 17, 2022	SELL	$82.16 - $96.94 $189,132 - $223,155	-2,302 Reduced 28.85%	5,678 $481,000
Q2 2022 Jul 13, 2022	SELL	$71.48 - $86.85 $32,451 - $39,429	-454 Reduced 5.38%	7,980 $661,000
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $237,027 - $295,773	-3,191 Reduced 27.45%	8,434 $650,000
Q4 2021 Feb 03, 2022	SELL	$71.72 - $91.47 $706,800 - $901,436	-9,855 Reduced 45.88%	11,625 $1.03 Million
Q3 2021 Nov 02, 2021	BUY	$74.77 - $85.47 $247,787 - $283,247	3,314 Added 18.24%	21,480 $1.66 Million
Q2 2021 Aug 10, 2021	BUY	$75.51 - $84.79 $646,969 - $726,480	8,568 Added 89.27%	18,166 $1.52 Million
Q1 2021 May 07, 2021	BUY	$74.73 - $90.69 $310,428 - $376,726	4,154 Added 76.3%	9,598 $724,000
Q4 2020 Feb 04, 2021	BUY	$72.61 - $90.2 $93,449 - $116,087	1,287 Added 30.96%	5,444 $477,000
Q3 2020 Oct 29, 2020	SELL	$71.87 - $131.03 $5,318 - $9,696	-74 Reduced 1.75%	4,157 $316,000
Q2 2020 Jul 27, 2020	BUY	$79.55 - $124.22 $336,576 - $525,574	4,231 New	4,231 $521,000
Q1 2018 May 09, 2018	SELL	$77.67 - $92.63 $194,874 - $232,408	-2,509 Closed	0 $0
Q4 2017 Feb 22, 2018	SELL	$80.76 - $95.13 $2,261 - $2,663	-28 Reduced 1.1%	2,509 $0
Q3 2017 Nov 07, 2017	BUY	$80.6 - $94.95 $15,475 - $18,230	192 Added 8.19%	2,537 $236,000
Q2 2017 Aug 08, 2017	BUY	N/A	2,345	2,345 $213,000

Others Institutions Holding BMRN

# of Institutions

641

Shares Held

178M

Call Options Held

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History